Aurobindo Pharma today posted a 6.29 per cent rise in its consolidated net profit at Rs 578.59 crore for the third quarter ended December 2016.
The company had posted a net profit of Rs 544.31 crore during the same period of previous fiscal. Net sales of the company rose to Rs 3,844.47 crore for the third quarter, as compared to Rs 3,442.18 crore in the same period of previous fiscal, Aurobindo Pharma said in a regulatory filing. “We remain focused on developing a differentiated and speciality product basket which will drive our future growth,” it said. Shares of the company ended 1.17 per cent up at Rs 706.40 on the BSE today.